• Citer

Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS)

par Bodoky, György;Cascinu, Stefano;Ajani, Jaffer J.A.;Scheulen, Max Ernst;Rivera, Fernando;Jassem, Jacek;Carrato, Alfredo;Moiseyenko, Vladimir;Vynnychenko, Ihor;Prausová, Jana;Van Laethem, Jean-Luc
Référence Journal of Gastrointestinal Cancer, 46, 2, page (109-117)
Publication Publié, 2015-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS)
Auteur:	Bodoky, György; Cascinu, Stefano; Ajani, Jaffer J.A.; Scheulen, Max Ernst; Rivera, Fernando; Jassem, Jacek; Carrato, Alfredo; Moiseyenko, Vladimir; Vynnychenko, Ihor; Prausová, Jana; Van Laethem, Jean-Luc
Informations sur la publication:	Journal of Gastrointestinal Cancer, 46, 2, page (109-117)
Statut de publication:	Publié, 2015-02
Sujet CREF:	Cardiologie et circulation
	Cancérologie
Mots-clés:	Advanced gastric cancer
	Cisplatin
	FLAGS trial
	Patient-reported outcomes
	Quality of life
	S-1
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1941-6628
	info:doi/10.1007/s12029-014-9680-1
	info:scp/84939460469